DEP Domain Containing 2 (DEPDC2) ELISA Kits

Functions as a RAC1 guanine nucleotide exchange factor (GEF), activating Rac proteins by exchanging bound GDP for free GTP. Zusätzlich bieten wir Ihnen DEP Domain Containing 2 Antikörper (14) und DEP Domain Containing 2 Proteine (4) und viele weitere Produktgruppen zu diesem Protein an.

list all ELISA KIts Gen GeneID UniProt
DEPDC2 80243 Q70Z35
DEPDC2 109294 Q3LAC4
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen

Top DEP Domain Containing 2 ELISA Kits auf

Showing 2 out of 7 products:

Katalog Nr. Reaktivität Sensitivität Bereich Bilder Menge Anbieter Lieferzeit Preis Details
Human 34 pg/mL 78-5000 pg/mL   96 Tests Anmelden zum Anzeigen 2 bis 3 Tage
  96 Tests Anmelden zum Anzeigen 11 bis 18 Tage

Weitere ELISA Kits für DEP Domain Containing 2 Interaktionspartner

Human DEP Domain Containing 2 (DEPDC2) Interaktionspartner

  1. Study demonstrates that miR-637 inhibites melanoma cell proliferation by activation of AKT signaling pathway and induces apoptosis through regulation of Bcl-2/Bax expression via targeting P-REX2a.

  2. MiR-338-3p suppresses the TNF-alpha-induced lipogenesis in sebocytes by targeting PREX2a and down-regulating PI3K/AKT signaling.

  3. Data suggest that PREX1 and PREX2 share similarities in amino acid sequence, domain structure, activation by PIP(3) [phosphatidylinositol 3,4,5-triphosphate] and G-protein-coupled receptors beta/gamma subunits; expression of PREX1 and PREX2 is altered in many cancers. [REVIEW]

  4. complex signaling mechanisms that involve PREX2, PI3K/AKT/PTEN and downstream epigenetic machinery to deregulate expression of key cell cycle regulators

  5. PREX2 was identified as a frequently mutated gene in human melanoma. .. mutation of PREX2 can accelerate human melanoma growth.

  6. The rapid tumor onset observed in this replication attempt, compared to the original study, makes the detection of accelerated tumor growth in PREX2 expressing NRAS(G12D) melanocytes extremely difficult.

  7. Elevated PREX2 protein expression is associated with pathogenesis of hepatocellular carcinoma.

  8. knockdown of PREX2a may effectively inhibit the malignant phenotype of glioma.

  9. The results of the present study suggested that PREX2a may act as an oncogene in osteosarcoma via the inhibition of PTEN activity and activation of PI3K signaling.

  10. findings identify PREX2 as a mediator of NRAS-mutant melanoma development that acts through the PI3K/PTEN/Akt pathway to regulate gene expression of a cell cycle regulator

  11. second messengers activate the Rac1 signal, which sets in motion a cascade whereby PAKs phosphorylate and negatively regulate PREX2 to decrease Rac1 activation.

  12. PREX2 mutants are likely selected in cancer to escape PTEN-mediated inhibition of invasion.

  13. CXCL9 is involved in the invasion ability of hepatocellular carcinoma cells possibly through up-regulation of its potential effector PREX2.

  14. Results demonstrate that miR-338-3p affects gastric cancer progression through PTEN-AKT signaling by targeting P-Rex2a in gastric cancer cells

  15. P-REX2 PH-domain-mediated inhibition of PTEN has a role in regulating insulin sensitivity and glucose homeostasis

  16. MiR-338-3p affects the PTEN/Akt pathway by down-regulating PREX2a.

  17. Studies indicate relevance of P-Rex1 and P-Rex2a, in breast tumorigenesis, and suggest that the exchange factors Vav2 and Vav3 play synergistic roles in breast cancer by sustaining tumor growth, neoangiogenesis, and metastasis.

  18. Analysis of whole-genome sequence data identified PREX2 (phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2)--a PTEN-interacting protein and negative regulator of PTEN in breast cancer--as a significantly mutated gene with a mutation frequency of approximately 14% in an independent extension cohort of 107 human melanomas

  19. suggests that aberrant control of PTEN by P-REX2a may represent a key tumorigenic mechanism, in agreement with recent studies supporting the pathological relevance of several other proposed PTEN regulators

  20. P-REX2 may serve as a novel link between Rac activation and the PI-3 kinase pathway.

DEP Domain Containing 2 (DEPDC2) Antigen-Profil

Beschreibung des Gens

Functions as a RAC1 guanine nucleotide exchange factor (GEF), activating Rac proteins by exchanging bound GDP for free GTP. Its activity is synergistically activated by phosphatidylinositol 3,4,5-trisphosphate and the beta gamma subunits of heterotrimeric G protein. Mediates the activation of RAC1 in a PI3K-dependent manner. May be an important mediator of Rac signaling, acting directly downstream of both G protein- coupled receptors and phosphoinositide 3-kinase (By similarity).

Genbezeichner und Symbole assoziert mit DEPDC2

  • phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2 (PREX2) Antikörper
  • phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2 (Prex2) Antikörper
  • 6230420N16Rik Antikörper
  • AI316880 Antikörper
  • AI553603 Antikörper
  • C030045D06Rik Antikörper
  • D430013K02 Antikörper
  • DEP.2 Antikörper
  • Depdc2 Antikörper
  • P-Rex2 Antikörper

Bezeichner auf Proteinebene für DEPDC2

DEP domain-containing protein 2 , PtdIns(3,4,5)-dependent Rac exchanger 2 , phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 2 protein , DEP domain containing 2 , ptdIns(3,4,5)-dependent Rac exchanger 2

80243 Homo sapiens
109294 Mus musculus
Ausgewählte Anbieter für DEP Domain Containing 2 (DEPDC2) ELISA Kits
Haben Sie etwas anderes gesucht?